Novel, long-duration treatment for glaucoma
US4906467A · kind A · utility
35Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 1988 |
| Grant date | Mar 6, 1990 |
| Priority date | — |
| Expiry date | Mar 24, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of and composition for reducing intraocular pressure. The method comprises administering to a patient requiring such reduction of intraocular pressure a therapeutically effective amount of 12(R)-hydroxy-eicosa-5,8,10,14-tetraenoic acid (12(R)-HETE). The method of the present invention is particularly useful in treatment of all types of glaucoma. The method is also useful in lowering intraocular pressure in preparation for eye surgery, particularly for the removal of cataracts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.